Rheumatoid Arthritis

🧠 Standard of Care

Rheumatoid Arthritis (RA) is a chronic inflammatory disorder where the immune system mistakenly attacks the synovium—the lining of the membranes that surround your joints. Early and aggressive treatment is critical to prevent irreversible joint damage.

• Early Diagnosis: The "window of opportunity" for treating RA is within the first few months of symptom onset. Rheumatologists use blood tests (Rheumatoid Factor, anti-CCP antibodies) and imaging (ultrasound, X-rays) to confirm the diagnosis.
• Treat-to-Target Strategy: Treatment goals are explicitly defined (usually clinical remission or low disease activity), and medications are adjusted frequently until that target is reached.
• Cardiovascular Risk: Systemic inflammation increases the risk of heart disease; thus, RA patients must have their cardiovascular risk factors (blood pressure, cholesterol) aggressively managed.

💊 Disease-Modifying Therapies

The cornerstone of RA treatment involves Disease-Modifying Antirheumatic Drugs (DMARDs), which slow disease progression and save the joints and other tissues from permanent damage.

Conventional DMARDs

Methotrexate is typically the first-line treatment for RA. Other conventional DMARDs include hydroxychloroquine, sulfasalazine, and leflunomide.

Biologic DMARDs

If conventional DMARDs fail to control the disease, targeted biologic therapies are introduced. These include TNF inhibitors (like Adalimumab or Etanercept), IL-6 inhibitors (Tocilizumab), and B-cell depleting agents (Rituximab).

Targeted Synthetic DMARDs (JAK Inhibitors)

Oral medications like Tofacitinib, Baricitinib, and Upadacitinib block the Janus kinase (JAK) pathways involved in the body's immune response. They are often used when patients do not respond well to biologics.

🏃‍♀️ Physical Therapy & Mobility

While medication controls inflammation, physical therapy is essential for maintaining joint function and muscle strength.

Occupational therapists can teach ways to perform daily tasks with less stress on the joints, and provide assistive devices (like specialized grips or splints) to protect joint alignment.

🔬 Active Clinical Trials

Research is continuously evaluating new pathways to target inflammation, as well as personalized medicine approaches to predict which patient will respond to which drug.

🥗 Dietary Interventions & Supplements

While medications are the primary driver of remission, anti-inflammatory dietary changes can offer adjunctive symptom relief.

• Mediterranean Diet: Rich in omega-3 fatty acids, antioxidants, and whole grains, this diet has been shown to modestly reduce pain and morning stiffness in RA patients.
• Omega-3 Supplements: Fish oil supplements can help decrease the production of inflammatory cytokines. Some patients find this allows them to reduce their NSAID usage.
• Vitamin D: Essential for bone health, which is particularly important as chronic inflammation and corticosteroid use both increase the risk of Osteoporosis in RA patients.

❓ Patient FAQ

Q: What is the difference between Osteoarthritis and Rheumatoid Arthritis?
A: Osteoarthritis is caused by mechanical wear and tear on joints over time. Rheumatoid Arthritis is an autoimmune disease where the immune system attacks the joint lining, causing severe systemic inflammation.

Q: Will I need to take medication forever?
A: Most patients with RA require long-term, ongoing medication to keep the disease in remission and prevent joint damage. Stopping medication often leads to a flare-up.

Q: Why do I take Folic Acid with Methotrexate?
A: Methotrexate depletes the body's folate levels, which can cause side effects like mouth sores and liver issues. Folic acid supplements help mitigate these side effects without reducing the drug's efficacy against RA.